⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

IONS News

Ionis Pharmaceuticals, Inc. Common Stock

Ionis receives U.S. FDA Breakthrough Therapy designation for ION582 in Angelman syndrome